0001493152-25-014941.txt : 20250925 0001493152-25-014941.hdr.sgml : 20250925 20250925161701 ACCESSION NUMBER: 0001493152-25-014941 CONFORMED SUBMISSION TYPE: SCHEDULE 13D/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20250925 DATE AS OF CHANGE: 20250925 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: RANGE IMPACT, INC. CENTRAL INDEX KEY: 0001438943 STANDARD INDUSTRIAL CLASSIFICATION: HEAVY CONSTRUCTION OTHER THAN BUILDING CONST - CONTRACTORS [1600] ORGANIZATION NAME: 05 Real Estate & Construction EIN: 753268988 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SCHEDULE 13D/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-84210 FILM NUMBER: 251343968 BUSINESS ADDRESS: STREET 1: 200 PARK AVENUE STREET 2: SUITE 400 CITY: CLEVELAND STATE: OH ZIP: 44122 BUSINESS PHONE: 530-231-7800 MAIL ADDRESS: STREET 1: 200 PARK AVENUE STREET 2: SUITE 400 CITY: CLEVELAND STATE: OH ZIP: 44122 FORMER COMPANY: FORMER CONFORMED NAME: MALACHITE INNOVATIONS, INC. DATE OF NAME CHANGE: 20211012 FORMER COMPANY: FORMER CONFORMED NAME: Vitality Biopharma, Inc. DATE OF NAME CHANGE: 20160721 FORMER COMPANY: FORMER CONFORMED NAME: Stevia First Corp. DATE OF NAME CHANGE: 20111020 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: LoConti Joseph E. CENTRAL INDEX KEY: 0001025708 ORGANIZATION NAME: FILING VALUES: FORM TYPE: SCHEDULE 13D/A MAIL ADDRESS: STREET 1: 6140 PARKLAND BLVD. CITY: MAYFIELD HEIGHTS STATE: OH ZIP: 44124 FORMER COMPANY: FORMER CONFORMED NAME: LOCONTI JOSEPH E DATE OF NAME CHANGE: 19961022 SCHEDULE 13D/A 1 primary_doc.xml SCHEDULE 13D/A 0001493152-25-003386 0001025708 XXXXXXXX LIVE 5 COMMON STOCK 09/23/2025 false 0001438943 92849B107 RANGE IMPACT, INC.

200 PARK AVENUE SUITE 4 CLEVELAND OH 44122

Howard Groedel 216.583.7000 1660 West 2nd Street, Suite 1100, Cleveland, OH 44113 0001025708 N Joseph E. LoConti AF N X1 26645789.00 0.00 26645789.00 0.00 26645789.00 N 23.73 IN COMMON STOCK RANGE IMPACT, INC. 200 PARK AVENUE SUITE 4 CLEVELAND OH 44122 This Amendment No. 5 ("Fifth Amendment") amends the Reporting Person's initial Schedule 13D filed on November 1, 2018, as amended on February 7, 2019, April 2, 2019, May 27, 2022 and January 23, 2025 (as amended, the "Schedule 13D") with respect to the shares of the Common Stock, par value $0.001 per share ("Common Stock"), of Range Impact, Inc. (the "Company"). Capitalized terms used but not otherwise defined in this Fifth Amendment have the meanings ascribed to such terms in the Schedule 13D. The purpose of this Fifth Amendment is to report a change in the number of shares of the Common Stock of the Company beneficially owned by the Reporting Person. The additional shares of Common Stock beneficially owned by the Reporting Person reflected on this Fifth Amendment were acquired by Tower IV LLC, an Ohio limited liability company ("Tower IV"), in a privately-negotiated transaction with the Company pursuant to a Securities Purchase Agreement between the Company and Tower IV, dated as of September 23, 2025 in exchange for $550,000. The funds used in making this purchase came from Tower IV's working capital. Mr. LoConti is the sole manager of Tower IV. Mr. LoConti has the sole power to vote and dispose of 26,645,789 shares of the Common Stock of the Company representing approximately 23.73% of the total number of shares of Common Stock of the Company outstanding as of the date of this Fifth Amendment. Not applicable. Tower IV acquired 2,333,333 shares of Common Stock of the Company in a privately-negotiated transaction pursuant to a Securities Purchase Agreement entered into between Tower IV and the Company, dated September 23, 2025. The consideration paid by Tower IV for the shares of Common Stock acquired pursuant to the Securities Purchase Agreement was $550,000 or $0.15 per share of Common Stock acquired. No other person is known by the Reporting Person to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the shares of Common Stock of the Company beneficially owned by the Reporting Person. Not applicable. Joseph E. LoConti /s/ Joseph E. LoConti 09/25/2025